LifeScience
Ailux and Eli Lilly Forge $345 Million AI-Driven Collaboration to Accelerate Bispecific Antibody Discovery
Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a stra...
November 06, 2025 | News
BioDlink and Lepu Biopharma Achieve China Approval for First-in-Class EGFR-Targeted ADC in Nasopharyngeal Carcinoma
BioDlink helps Lepu Biopharma win China's marketing approval for EGFR-targeted ADC treating recurrent or metastatic nasopharyngeal carcinoma T...
November 06, 2025 | News
Takeda’s QDENGA Trial Confirms Sustained Protection and Favourable Safety Over Seven Years
Findings Reinforce QDENGA’s Long-Term Safety Profile and Two-Dose Vaccination Schedule QDENGA is the Longest-Studied Dengue Vaccine and the ...
November 06, 2025 | News
Sartorius and Aber Instruments Launch Single-Use BioPAT® Viamass Sensor for End-to-End Bioprocess Scalability
The single-use capacitance sensor now enables high-resolution, inline biomass measurement from small-scale Ambr® experiments to large-scale Biostat S...
November 05, 2025 | News
LakeShore Biopharma to Go Private in US$37 Million Merger with Oceanpine Group
LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discove...
November 05, 2025 | News
AVEO and HiberCell Partner to Develop First-in-Human PERK Inhibitor for Kidney Cancer
First-in-Human PERK inhibitor (HC-5404) to be developed in combination with AVEO's FOTIVDA® (tivozanib) for RCC – – AVEO...
November 05, 2025 | News
Bio-Techne and Nucleai Demonstrate Predictive Power of Spatial Biomarkers in Melanoma
Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomar...
November 05, 2025 | News
Sanyou Biopharmaceuticals and Shanghai ZJ Bio-Tech Forge Strategic Partnership to Accelerate Automated Development of Innovative Biologics
Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter referre...
November 04, 2025 | News
4D Molecular Therapeutics and Otsuka Form $471 Million Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacific
4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...
November 04, 2025 | News
NovaBridge Subsidiary Visara Assigns Exclusive License for VIS-101 to Everest Medicines to Advance Treatment for Wet AMD Across Asia
NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet...
November 03, 2025 | News
Australis Scientific Wins 2025 MedTech Innovator Asia Pacific Grand Prize for Smart Neuromodulation Patch Treating Overactive Bladder
Medical device company developing smart patch delivering minimally invasive neuromodulation therapy for overactive bladder, is awarded Grand Prize of USD 1...
October 31, 2025 | News
Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
Thermo Fisher Scientific has inaugurated the expanded Research and Development (R&D) Centre of Excellence in Bengaluru, marking a major step in advanci...
October 28, 2025 | News
Nielsen BioSciences and Maruho Expand Licensing Agreement for CANDIN Across Key Asian Markets
Expansion of licensing agreement extends CANDIN’s development to key Asian growth markets including China, South Korea and Taiwan--and broadens the...
October 27, 2025 | News
WuXi AppTec Reports RMB32.86 Billion Revenue for First Three Quarters of 2025, Up 18.6% Year-on-Year
Q3 Total Revenue: RMB12.06 Billion, Up 15.3% YoY; Revenue from Continuing Operations[1]Reached RMB12.04 Billion, Up 19.7% YoY Q1-Q3 Total Re...
October 27, 2025 | Company results
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
